Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Jagsonpal Pharmaceuticals Limited
JAGSNPHARM | NSE
203.04
INR-0.41
-0.20%
JAGSNPHARM | NSE
Loading StockChartView...
About Jagsonpal Pharmaceuticals Limited
Sector
Healthcare
Industry
Drug Manufacturers-Specialty & Generic
Earnings date
31/03/2024
As of date
05/06/2026
Close
203.04
Open
203.45
High
206.00
Low
202.00
Jagsonpal Pharmaceuticals Limited develops and manufactures bulk drugs and pharmaceutical formulations in the areas of women health pain and analgesics and general medicine. It offers general medicines such as allergy management immunity and cell protection gut and mind management anti-infectives and dentist and ENT range products; and women's healthcare products including pregnancy care and dysfunctional uterine bleeding complications and management products. The company also provides pain and analgesics products in the areas of pain management and bone and joint care. It offers drugs in the form of tablets capsules and syrups. The company was founded in 1964 and is headquartered in New Delhi India. Jagsonpal Pharmaceuticals Limited is a subsidiary of Aresko Progressive Private Limited.
View LessJAGSNPHARM | NSE
Risk
33.2
Sharpe
-0.43
Luna's Score
43/100
Recommendation
Sell
Luna says (JAGSNPHARM | NSE)
What's Working
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
What's not Working
Negative Momentum (Declining Price)
Price Below SMA10D
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
Loading RiskMeterView...
10 days
13.8%1 month
33.2%3 months
34.0%6 months
35.7%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
61.65
Fwd. PE
-
Price to book
6.69
Debt to equity
0.05
Debt to assets
0.04
Ent. to EBITDA
34.57
Ent. to rev.
5.35
PEG
-
Other Fundamentals
EBITDA
241.98M
MarketCap
5.39B
MarketCap(USD)
56.74M
Div. yield
1.06
Op. margin
14.92
Erngs. growth
-32.30
Rev. growth
2.10
Ret. on equity
12.97
Short ratio
-
Short perc.
-
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
13.96
Range1M
30.51
Range3M
63.12
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
0.24
Price X volume
5.14M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 34.57 | 24.85 | Expensive |
| Ent. to Revenue | 5.35 | 11.40 | Cheaper |
| PE Ratio | 61.65 | 51.36 | Expensive |
| Price to Book | 6.69 | 6.83 | Par |
| Dividend Yield | 1.06 | 0.52 | Leader |
| Std. Deviation (3M) | 34.00 | 42.17 | Par |
| Debt to Equity | 0.05 | 0.35 | Cheaper |
| Debt to Assets | 0.04 | 0.17 | Cheaper |
| Market Cap | 5.39B | 290.82B | Emerging |
